Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.CNS drugs · 2026-08-13Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12Psilocybin Recovery Intervention for Stopping Methamphetamine UseClinicalTrials.gov · 2026-08-11Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-22Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Psychopharmacology · 2026-07-01Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01The relevance of the 5HT2A-mGlu2 heterodimer in explaining the clinical ambivalence of psilocybinRevista de Neuro-Psiquiatría · 2026-06-30Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitaloprambioRxiv · 2026-06-26Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-23Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation TheorembioRxiv · 2026-06-16Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase developmentJournal of Drug Delivery Science and Technology · 2026-06-01Therapeutic advances in fibromyalgia: one year in review 2026.Clinical and experimental rheumatology · 2026-06-01Synthesis of Amines for Active Pharmaceutical Ingredients Using the Whole-Cell Factory Saccharomyces Cerevisae.Chembiochem: a European journal of chemical biology · 2026-05-14Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.Journal of psychopharmacology (Oxford, England) · 2026-05-01Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-04-01Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.Expert opinion on pharmacotherapy · 2026-04-01Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.International journal of molecular sciences · 2026-03-20Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-10Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in ratsResearch Square · 2026-02-23Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal ExtractJournal of the Brazilian Chemical Society · 2026-01-01Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortexbioRxiv · 2025-12-26Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-19Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Molecular psychiatry · 2025-12-01Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Molecular psychiatry · 2025-12-01Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?Medical sciences (Basel, Switzerland) · 2025-11-20N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-11-01Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.EClinicalMedicine · 2025-11-01Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applicationsCaderno Pedagógico · 2025-10-31Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.Psychiatry research · 2025-10-01Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin CompoundsACS Omega · 2025-09-30Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24Psilocybin: Systematic review of its use in the treatment of depressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2025-08-26631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTSThe international journal of neuropsychopharmacology · 2025-08-01363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIORThe international journal of neuropsychopharmacology · 2025-08-01Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis MushroomsACS Omega · 2025-07-22Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometry.Journal of analytical toxicology · 2025-07-01Chemical Composition and Biological Activities of Mushrooms: Gaps and Perspectives.Pharmaceuticals (Basel, Switzerland) · 2025-07-01Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic ExperienceBrain and Behavior · 2025-06-30Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.Translational psychiatry · 2025-06-14Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Neuroscience and biobehavioral reviews · 2025-06-01There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.The American journal of psychiatry · 2025-06-01In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025-05-22Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?Neurobiology of stress · 2025-05-01Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Pharmacokinetics of Psilocybin: A Systematic Review.Pharmaceutics · 2025-03-25Psychedelics Align Brain Activity with ContextbioRxiv · 2025-03-11Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their ImplicationsPharmaceuticals · 2025-03-07Psychedelics and Suicide-Related Outcomes: A Systematic Review.Journal of clinical medicine · 2025-02-20Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.Expert opinion on drug discovery · 2025-02-03Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.Expert review of neurotherapeutics · 2025-02-01Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatmentbioRxiv · 2025-01-02Alternative therapy for neurological and psychiatric disorders using psilocybinSão Paulo Medical Journal · 2025-01-01Psilocybin: From Psychiatric Pariah to Perceived Panacea.The American journal of psychiatry · 2025-01-01Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.International journal of medicinal mushrooms · 2025-01-01A review of psychedelics trials completed in depression, informed by European regulatory perspectives.Neuroscience applied · 2025-01-01Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexitybioRxiv · 2024-12-22Impact of psilocybin on cognitive function: A systematic review.Psychiatry and clinical neurosciences · 2024-12-01The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.CNS spectrums · 2024-12-01Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-19Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussionsmedRxiv · 2024-07-12Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.Clinical case reports · 2024-06-01THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male miceJournal of Hepatology · 2024-05-31Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT.bioRxiv: the preprint server for biology · 2024-05-30Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related PsychopathologyPsyArXiv · 2024-05-26Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.Journal of ethnopharmacology · 2024-02-10Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-02-01Must Psilocybin Always "Assist Psychotherapy"?The American journal of psychiatry · 2024-01-01Is there credible evidence to assert psilocybin-assisted therapy for depression?European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2024-01-01Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.The American journal of psychiatry · 2024-01-01Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators.Frontiers in pharmacology · 2024-01-01Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samplesJournal of Analytical Toxicology · 2023-12-12Self-perception and self-recognition while looking in the mirror on psilocybinJournal of Psychedelic Studies · 2023-09-19The therapeutic potential of psilocybin in depression resistant to psychotropic drugsEuropean psychiatry: the journal of the Association of European Psychiatrists · 2023-07-19No trip needed for psychedelics to lift mood?Science (New York, N.Y.) · 2023-06-09Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.Journal of psychiatric research · 2023-05-01Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signalingCNS Neuroscience & Therapeutics · 2023-03-01Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs.Veterinary and animal science · 2023-03-01Indigenous-Amazonian Traditional Medicine's Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study.Plants (Basel, Switzerland) · 2023-01-11The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.International journal of molecular sciences · 2023-01-10Italian psychedelic therapies of the past century: An historical overviewDrug Science Policy and Law · 2023-01-01Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.Journal of psychoactive drugs · 2023-01-01Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.Frontiers in psychiatry · 2023-01-01Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature communications · 2022-10-03Prevalence and associations of classic psychedelic-related seizures in a population-based sample.Drug and alcohol dependence · 2022-10-01Brain dynamics predictive of response to psilocybin for treatment-resistant depressionResearch Square · 2022-09-20Brain dynamics predictive of response to psilocybin for treatment-resistant depressionbioRxiv · 2022-07-04Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-07-01Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi ().Journal of fungi (Basel, Switzerland) · 2022-06-02Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.Molecules (Basel, Switzerland) · 2022-04-14Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.Fungal biology · 2022-04-01Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network neuroscience (Cambridge, Mass.) · 2022-01-01Rediscovering Psilocybin as an Antidepressive Treatment Strategy.Pharmaceuticals (Basel, Switzerland) · 2021-09-28A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small RNA.Cell reports · 2021-07-20Registered clinical studies investigating psychedelic drugs for psychiatric disorders.Journal of psychiatric research · 2021-07-01Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theorybioRxiv · 2021-05-17The Therapeutic Potential of Psilocybin.Molecules (Basel, Switzerland) · 2021-05-15Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/PsilocinClinical Pharmacology in Drug Development · 2021-01-01Psilocybin rescues sociability deficits in an animal model of autismbioRxiv · 2020-09-10Dynamic coupling of whole-brain neuronal and neurotransmitter systems.Proceedings of the National Academy of Sciences of the United States of America · 2020-04-28Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.Journal of experimental pharmacology · 2020-01-01Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01Altered trajectories in the dynamical repertoire of functional network states under psilocybinbioRxiv · 2018-07-25Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.Progress in brain research · 2018-01-01Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-10-01ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.ChemInform · 2016-07-01DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocinJournal of Pharmaceutical and Biomedical Analysis · 2016-06-01Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotoninTetrahedron · 2016-05-01The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey.Cephalalgia: an international journal of headache · 2016-02-01Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and PsilocinJournal of Analytical & Bioanalytical Techniques · 2015-01-01Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers.Journal of pharmaceutical and biomedical analysis · 2014-11-01Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.Natural product reports · 2014-07-01Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushroomsDrug Testing and Analysis · 2011-09-01Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2011-02-02Effects of Psilocybe argentipes on marble-burying behavior in mice.Bioscience, biotechnology, and biochemistry · 2009-08-01[Simple and rapid screening for psychotropic natural products using Direct Analysis in Real Time (DART)-TOFMS].Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan · 2009-06-01HPLC/DAD analysis of psilocin and psilocybin in psilocybe cubensisMeeting on Recent Developments in Pharmaceutical Analysis · 2007-01-01Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection.Talanta · 2005-04-30[DNA and chemical analyses of commercial fly agaric-related products].Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan · 2005-04-01Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometryAnalytica Chimica Acta · 2004-12-01Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom”Journal of Natural Products · 2003-06-01[Discrimination of psychoactive fungi (commonly called "magic mushrooms") based on the DNA sequence of the internal transcribed spacer region].Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan · 2003-02-01[Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning].Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica · 1988-01-01Poisoning by hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes K. Yokoyama) indigenous to Japan.The Tohoku journal of experimental medicine · 1986-01-01ChemInform Abstract: COMPARISON OF SOLUTION CONFORMATIONAL PREFERENCES FOR THE HALLUCINOGENS BUFOTENIN AND PSILOCIN USING 360-MHZ PROTON NMR SPECTROSCOPYChemischer Informationsdienst · 1981-07-14Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopyJournal of Medicinal Chemistry · 1981-02-01[PSYCHOMIMETIC SUBSTANCES. (CONTRIBUTION TO THE CLINICAL PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN)].Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali · 1963-09-30